1707 — Grape King Bio Balance Sheet
0.000.00%
- TWD18.29bn
- TWD15.98bn
- TWD11.16bn
- 95
- 69
- 16
- 67
Annual balance sheet for Grape King Bio, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,005 | 3,897 | 4,790 | 4,970 | 4,432 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 205 | 314 | 284 | 315 | 336 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,971 | 4,985 | 5,801 | 6,039 | 5,596 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,532 | 7,483 | 7,650 | 7,795 | 7,949 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 13,104 | 14,061 | 15,053 | 15,512 | 15,324 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,501 | 3,294 | 3,712 | 3,647 | 3,323 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,480 | 5,073 | 5,483 | 5,534 | 5,268 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 6,624 | 8,988 | 9,570 | 9,978 | 10,056 |
| Total Liabilities & Shareholders' Equity | 13,104 | 14,061 | 15,053 | 15,512 | 15,324 |
| Total Common Shares Outstanding |